BLM (RecQ-like DNA helicase BLM) variants and mutations
BLM (also known as RecQ-like DNA helicase BLM) is a human protein-coding gene encoding a recQ-like DNA helicase protein. It unwinds complex DNA structures and helps resolve homologous-recombination intermediates, thereby suppressing inappropriate sister-chromatid exchanges and maintaining genome stability. Biallelic loss-of-function variants cause Bloom syndrome, characterized by growth deficiency, chromosome instability, and marked cancer predisposition. This analysis covers 3,337 BLM variants and mutations. Of these, 69% have computational variant effect predictions. Disease context includes Bloom syndrome, Inherited cancer-predisposing syndrome, and hereditary neoplastic syndrome. Example BLM variants include M1L, M1T, and M1V.
Variant analysis overview
- Gene: BLM
- Protein: RecQ-like DNA helicase BLM
- UniProt accession: P54132
- Organism: Homo sapiens
- Variants analyzed: 3337
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 3,086 unspecified-consequence records; 77 missense variants; 125 synonymous variants; 31 frameshift variants; 5 stop-gained variants; 11 in-frame deletions; 2 in-frame insertions; 1 splice-region variants; 1 substitution
- Prediction scores: 2,295 variants have prediction scores (69% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Bloom syndrome, Inherited cancer-predisposing syndrome, hereditary neoplastic syndrome, cancer, colorectal cancer, leukemia, lymphoma, Immunodeficiency, immune system disorder, immunodeficiency disease, neurodegenerative disease, acute myeloid leukemia.
Protein structure and variant hotspots
- Protein features: 3 domains; 8 binding sites; 20 post-translational modification sites.
- Structural context: 798 variants have structural context.
- PTM context: 43 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable BLM variants
Examples include M1L, M1T, M1V, A2D, A2S, A2V, A2A, A3G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1L (p.Met1Leu), rs1215497457, ClinGen CA393838752, ClinVar RCV000674307, MetaLR 0.45, MetaSVM -0.08, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- M1T (p.Met1Thr), rs1057516593, ClinGen CA16041764, ClinVar RCV000412038, ClinVar RCV003168589, MetaLR 0.47, MetaSVM -0.00, Uncertain significance, Bloom syndrome
- M1V (p.Met1Val), rs1215497457, ClinGen CA393838753, ClinVar RCV003614255, MetaLR 0.45, MetaSVM -0.08, Uncertain significance, Bloom syndrome
- A2D (p.Ala2Asp), rs2505384668, ClinGen CA393838764, ClinVar RCV002357966, Uncertain significance, Hereditary cancer-predisposing syndrome
- A2S (p.Ala2Ser), rs199769364, ClinGen CA274726271, ClinVar RCV000703785, ClinVar RCV002334373, REVEL 0.09, CADD 23.90, Uncertain significance, Bloom syndrome; Hereditary cancer-predisposing syndrome
- A2V (p.Ala2Val), gnomAD 15-90747397-C-T, REVEL 0.18, CADD 25.20
- A2A (p.Ala2Ala), gnomAD 15-90747398-T-C, CADD 12.20
- A3G (p.Ala3Gly), ExAC rs200399224, gnomAD rs200399224, REVEL 0.06, CADD 22.40
- A3T (p.Ala3Thr), rs1895531822, ClinGen CA393838765, cosmic curated COSV61926, ClinVar RCV001040222, AlphaMissense 0.16, MetaLR 0.15, Uncertain significance, Bloom syndrome
- A3V (p.Ala3Val), ExAC rs200399224, gnomAD rs200399224
- A3S (p.Ala3Ser), gnomAD 15-90747399-G-T, REVEL 0.07, CADD 21.90
- A3A (p.Ala3Ala), rs1596215598, gnomAD 15-90747401-T-C, CADD 9.55
- V4A (p.Val4Ala), rs144706057, ClinGen CA287052, cosmic curated COSV10466, ClinVar RCV000115279, REVEL 0.12, CADD 23.60, Conflicting interpretations, Hereditary cancer; Hereditary cancer-predisposing syndrome; not specified
- V4D (p.Val4Asp), rs144706057, ClinGen CA7738223, ClinVar RCV001968253, ClinVar RCV004044456, REVEL 0.27, CADD 26.00, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- V4F (p.Val4Phe), rs1466614215, ClinGen CA393838772, cosmic curated COSV61927, ClinVar RCV001930447, AlphaMissense 0.13, MetaLR 0.05, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- V4I (p.Val4Ile), rs1466614215, ClinGen CA393838770, ClinVar RCV001359717, gnomAD rs1466614215, REVEL 0.03, AlphaMissense 0.13, Uncertain significance, Bloom syndrome
- V4L (p.Val4Leu), rs1466614215, ClinGen CA393838771, ClinVar RCV002001300, gnomAD rs1466614215, AlphaMissense 0.13, MetaLR 0.05, Uncertain significance, Bloom syndrome
- P5L (p.Pro5Leu), rs1567034056, ClinGen CA393838778, ClinVar RCV000709353, Ensembl rs1567034056, AlphaMissense 0.71, MetaLR 0.72, Uncertain significance, Bloom syndrome
- P5S (p.Pro5Ser), rs760982604, ClinGen CA7738224, ClinVar RCV000699588, ExAC rs760982604, AlphaMissense 0.74, MetaLR 0.72, Uncertain significance, Bloom syndrome
- Q6P (p.Gln6Pro), rs1248128883, ClinGen CA393838782, ClinVar RCV000803339, ClinVar RCV005520349, AlphaMissense 0.11, MetaLR 0.18, Uncertain significance, Bloom syndrome; Hereditary cancer-predisposing syndrome
- Q6R (p.Gln6Arg), gnomAD rs1248128883, REVEL 0.06, AlphaMissense 0.11, Uncertain significance, Bloom syndrome
- Q6Q (p.Gln6Gln), rs372771577, gnomAD 15-90747410-A-G, CADD 0.44
- N7S (p.Asn7Ser), rs2505384820, ClinGen CA393838794, ClinVar RCV003341941, Uncertain significance, Hereditary cancer-predisposing syndrome
- N7I (p.Asn7Ile), gnomAD 15-90747408-CA-C, CADD 23.60
- N8K (p.Asn8Lys), rs1060500635, ClinGen CA16614536, ClinVar RCV000469793, ClinVar RCV005520279, REVEL 0.34, CADD 23.00, Uncertain significance, Bloom syndrome; Hereditary cancer-predisposing syndrome
- L9P (p.Leu9Pro), gnomAD rs1189105027, REVEL 0.67, CADD 26.90
- L9V (p.Leu9Val), rs1596215640, ClinGen CA393838813, NCI-TCGA Cosmic COSV6192, ClinVar RCV001016066, AlphaMissense 0.48, MetaLR 0.58, Uncertain significance, Hereditary cancer-predisposing syndrome
- L9I (p.Leu9Ile), gnomAD 15-90747417-C-A, REVEL 0.29, CADD 25.90
- Q10* (p.Gln10Ter), rs776826506, ClinGen CA7738226, ClinVar RCV002635373, ExAC rs776826506, Pathogenic
- Q10R (p.Gln10Arg), rs2505384873, ClinGen CA393838825, ClinVar RCV003356975, Uncertain significance, Hereditary cancer-predisposing syndrome
- Q10K (p.Gln10Lys), gnomAD 15-90747420-C-A, REVEL 0.14, CADD 23.90
- Q10Q (p.Gln10Gln), rs2151145010, gnomAD 15-90747422-G-A, CADD 7.92
- E11G (p.Glu11Gly), rs2505384885, ClinGen CA393838839, ClinVar RCV004519156, REVEL 0.14, CADD 31.00, Uncertain significance, Hereditary cancer-predisposing syndrome
- E11D (p.Glu11Asp), gnomAD 15-90747425-G-C, REVEL 0.11, CADD 21.20
- L13L (p.Leu13Leu), gnomAD 15-90747429-C-T, CADD 11.60
- E14G (p.Glu14Gly), ExAC rs759714714, TOPMed rs759714714, gnomAD rs759714714, REVEL 0.15, CADD 25.80, Uncertain significance, Hereditary cancer-predisposing syndrome
- E14K (p.Glu14Lys), rs2505384925, ClinGen CA393838866, ClinVar RCV002650970, Uncertain significance, Bloom syndrome
- E14Q (p.Glu14Gln), rs2505384925, ClinGen CA393838868, ClinVar RCV002323333, Uncertain significance, Hereditary cancer-predisposing syndrome
- R15C (p.Arg15Cys), rs148545569, ClinGen CA7738228, cosmic curated COSV61922, ClinVar RCV000227410, REVEL 0.18, CADD 29.70, Conflicting interpretations, Hereditary cancer-predisposing syndrome; not specified; not provided
- R15H (p.Arg15His), rs752755503, ClinGen CA7738229, ClinVar RCV000463869, ClinVar RCV000779839, REVEL 0.21, CADD 25.40, Uncertain significance, Hereditary cancer-predisposing syndrome; not provided; Hereditary cancer
- R15S (p.Arg15Ser), rs148545569, ClinGen CA274726323, ClinVar RCV001990389, ClinVar RCV003303521, REVEL 0.19, CADD 24.40, Conflicting interpretations, Hereditary cancer-predisposing syndrome; Bloom syndrome
- R15L (p.Arg15Leu), gnomAD 15-90747436-G-T, REVEL 0.10, CADD 19.00
- R15R (p.Arg15Arg), rs1458732220, gnomAD 15-90747437-T-C, CADD 8.46
- H16D (p.His16Asp), rs1895533888, ClinGen CA393838887, ClinVar RCV001235189, Ensembl rs1895533888, AlphaMissense 0.82, MetaLR 0.29, Uncertain significance, Bloom syndrome
- H16Y (p.His16Tyr), rs1895533888, ClinGen CA393838889, ClinVar RCV002335300, ClinVar RCV003775949, AlphaMissense 0.82, MetaLR 0.29, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- H16Q (p.His16Gln), gnomAD 15-90747440-C-G, REVEL 0.22, CADD 22.60
- S17L (p.Ser17Leu), rs2151145042, ClinGen CA393838908, ClinVar RCV001364605, Ensembl rs2151145042, AlphaMissense 0.20, MetaLR 0.43, Uncertain significance, Bloom syndrome
- A18V (p.Ala18Val), rs2151145051, ClinGen CA393838914, ClinVar RCV003506704, Ensembl rs2151145051, AlphaMissense 0.24, MetaLR 0.34, Uncertain significance, Bloom syndrome
- A18A (p.Ala18Ala), rs1895534219, gnomAD 15-90747446-C-G, CADD 10.30
- R19K (p.Arg19Lys), rs2151145055, ClinGen CA393838917, ClinVar RCV001934232, Ensembl rs2151145055, AlphaMissense 0.08, MetaLR 0.06, Uncertain significance, Bloom syndrome
- R19S (p.Arg19Ser), rs1555418008, ClinGen CA393838921, ClinVar RCV000560243, ClinVar RCV001024545, REVEL 0.11, CADD 23.80, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- R19R (p.Arg19Arg), gnomAD 15-90747449-A-G, CADD 12.90
- T20I (p.Thr20Ile), rs1895534435, ClinGen CA393838927, ClinVar RCV002357953, gnomAD rs1895534435, REVEL 0.04, CADD 11.50, Uncertain significance, Hereditary cancer-predisposing syndrome
- T20T (p.Thr20Thr), rs1596215695, gnomAD 15-90747452-A-G, CADD 9.86
- L21V (p.Leu21Val), rs2505385068, ClinGen CA2697549315, ClinVar RCV003506003, Uncertain significance, Bloom syndrome
- N22D (p.Asn22Asp), rs1370338581, ClinGen CA393838935, ClinVar RCV000819153, ClinVar RCV001025340, AlphaMissense 0.10, MetaLR 0.10, Uncertain significance, Bloom syndrome; Hereditary cancer-predisposing syndrome
- N23N (p.Asn23Asn), gnomAD 15-90747461-T-C, CADD 8.98
- K24T (p.Lys24Thr), gnomAD 15-90747463-A-C, REVEL 0.10, CADD 21.60
- L25* (p.Leu25Ter), rs1895534883, ClinGen CA393838962, ClinVar RCV001878750, Ensembl rs1895534883, AlphaMissense 0.10, MetaLR 0.16, Pathogenic
- L25F (p.Leu25Phe), rs1276887266, ClinGen CA393838963, ClinVar RCV002394213, REVEL 0.06, CADD 9.97, Uncertain significance, Hereditary cancer-predisposing syndrome
- L25S (p.Leu25Ser), rs1895534883, ClinGen CA393838961, ClinVar RCV001318695, ClinVar RCV003346460, AlphaMissense 0.10, MetaLR 0.16, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome; not provided
- L25L (p.Leu25Leu), rs1276887266, gnomAD 15-90747467-A-G, CADD 6.34
- S26N (p.Ser26Asn), rs1895535200, ClinGen CA393838968, ClinVar RCV004521596, ClinVar RCV006488728, REVEL 0.07, CADD 9.23, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- S26G (p.Ser26Gly), gnomAD 15-90747468-A-G, REVEL 0.16, CADD 18.20
- S26I (p.Ser26Ile), gnomAD 15-90747469-G-T, REVEL 0.17, CADD 21.70
- L27F (p.Leu27Phe), rs1368566341, ClinGen CA393838977, ClinVar RCV002419144, ClinVar RCV003776468, AlphaMissense 0.07, MetaLR 0.08, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- L27I (p.Leu27Ile), gnomAD rs1368566341, REVEL 0.06, AlphaMissense 0.07, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- L27P (p.Leu27Pro), gnomAD 15-90747472-T-C, REVEL 0.04, CADD 22.00
- S28* (p.Ser28Ter), rs2151145090, ClinGen CA393838988, ClinVar RCV004521617, ClinGen CA393838990, CADD 37.00, Pathogenic
- S28P (p.Ser28Pro), gnomAD 15-90747474-T-C, REVEL 0.15, CADD 20.70
- K29R (p.Lys29Arg), rs1895535585, ClinGen CA393838999, ClinVar RCV001279093, ClinVar RCV004951441, REVEL 0.05, CADD 23.20, Uncertain significance, Hereditary cancer-predisposing syndrome
- K29K (p.Lys29Lys), rs1895535691, gnomAD 15-90747479-A-G, CADD 8.43
- P30A (p.Pro30Ala), rs2151145103, ClinGen CA393839007, ClinVar RCV002376050, ClinVar RCV006559183, AlphaMissense 0.10, MetaLR 0.27, Uncertain significance, Bloom syndrome; Hereditary cancer-predisposing syndrome
- P30L (p.Pro30Leu), cosmic curated COSV61926, gnomAD rs1223618819, Uncertain significance, Hereditary cancer-predisposing syndrome
- P30Q (p.Pro30Gln), gnomAD rs1223618819
- P30R (p.Pro30Arg), NCI-TCGA Cosmic COSV6192, cosmic curated COSV61922, Variant assessed as somatic; moderate impact.
- P30T (p.Pro30Thr), rs2151145103, ClinGen CA393839006, ClinVar RCV002376046, ClinVar RCV005097289, AlphaMissense 0.10, MetaLR 0.27, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- S33* (p.Ser33Ter), 1000Genomes rs139282091, ExAC rs139282091, TOPMed rs139282091, gnomAD rs139282091, Uncertain significance
- S33L (p.Ser33Leu), rs139282091, ClinGen CA157400, NCI-TCGA Cosmic COSV9904, cosmic curated COSV99049, REVEL 0.03, CADD 14.70, Uncertain significance, Hereditary cancer-predisposing syndrome; not provided; Bloom syndrome
- S33P (p.Ser33Pro), gnomAD rs1286825856, REVEL 0.16, CADD 22.20
- G34D (p.Gly34Asp), gnomAD 15-90749369-G-A, REVEL 0.18, CADD 24.60
- T36A (p.Thr36Ala), rs1714362154, ClinGen CA393839306, ClinVar RCV002024609, ClinVar RCV002407317, REVEL 0.15, CADD 25.30, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- T36S (p.Thr36Ser), rs1895599706, ClinGen CA393839311, ClinVar RCV001228750, Ensembl rs1895599706, AlphaMissense 0.16, MetaLR 0.30, Uncertain significance, Bloom syndrome
- F37L (p.Phe37Leu), gnomAD 15-90749375-CT-C, CADD 26.70
- K38R (p.Lys38Arg), rs2151146691, ClinGen CA393839335, ClinVar RCV002002879, Ensembl rs2151146691, AlphaMissense 0.08, MetaLR 0.45, Uncertain significance, Bloom syndrome
- K38T (p.Lys38Thr), rs2151146691, ClinGen CA393839333, ClinVar RCV001968178, ClinVar RCV002458894, REVEL 0.49, AlphaMissense 0.08, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- K38K (p.Lys38Lys), rs770017301, gnomAD 15-90749382-A-G, CADD 8.76
- K39M (p.Lys39Met), rs2505390131, ClinGen CA393839348, ClinVar RCV002329876, Uncertain significance, Hereditary cancer-predisposing syndrome
- T41I (p.Thr41Ile), rs533736036, ClinGen CA7738247, ClinVar RCV001361883, ClinVar RCV002377513, REVEL 0.07, CADD 10.60, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- T41K (p.Thr41Lys), gnomAD 15-90749390-C-A, REVEL 0.06, CADD 16.30
- T41T (p.Thr41Thr), gnomAD 15-90749391-A-G, CADD 1.90
- S42F (p.Ser42Phe), rs763065919, ClinGen CA393839384, ClinVar RCV001374248, ExAC rs763065919, REVEL 0.10, CADD 20.30, Uncertain significance, Bloom syndrome
- S42P (p.Ser42Pro), rs1291378382, ClinGen CA393839378, ClinVar RCV000575777, ClinVar RCV000628623, REVEL 0.04, CADD 3.69, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome; not provided
- S42Y (p.Ser42Tyr), cosmic curated COSV61927, ExAC rs763065919, gnomAD rs763065919, REVEL 0.10, CADD 22.00, Uncertain significance
- S43L (p.Ser43Leu), rs2505390179, ClinGen CA393839394, ClinVar RCV002383281, ClinVar RCV005097406, REVEL 0.05, CADD 10.80, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- S43S (p.Ser43Ser), rs767605181, gnomAD 15-90749397-A-G, CADD 2.34
- D44G (p.Asp44Gly), rs1895600607, ClinGen CA393839406, ClinVar RCV001240527, ClinVar RCV006372350, AlphaMissense 0.07, MetaLR 0.03, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- D44N (p.Asp44Asn), rs1249086421, ClinGen CA393839397, ClinVar RCV002385414, ClinVar RCV003614144, REVEL 0.06, CADD 14.90, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- D44V (p.Asp44Val), rs1895600607, ClinGen CA393839404, ClinVar RCV002385644, AlphaMissense 0.07, MetaLR 0.03, Uncertain significance, Hereditary cancer-predisposing syndrome
- D44Y (p.Asp44Tyr), rs1249086421, ClinGen CA393839400, ClinVar RCV001958283, gnomAD rs1249086421, REVEL 0.09, CADD 18.90, Uncertain significance, Bloom syndrome
- N45D (p.Asn45Asp), rs2505390218, ClinGen CA393839413, ClinVar RCV003614891, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- N45S (p.Asn45Ser), rs1555418242, ClinGen CA393839418, cosmic curated COSV61926, ClinVar RCV000529582, REVEL 0.03, CADD 0.96, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary breast ovarian cancer syndro
- N46D (p.Asn46Asp), rs2505390232, ClinGen CA393839427, ClinVar RCV002383662, Likely benign, Hereditary cancer-predisposing syndrome
- N46K (p.Asn46Lys), rs1895600929, ClinGen CA393839438, ClinVar RCV001051814, ClinVar RCV002393260, AlphaMissense 0.12, MetaLR 0.09, Uncertain significance, Hereditary cancer-predisposing syndrome; not provided; Bloom syndrome
- N46S (p.Asn46Ser), rs1237910576, ClinGen CA393839432, ClinVar RCV000699899, ClinVar RCV001030678, REVEL 0.06, CADD 1.76, Conflicting interpretations, Bloom syndrome; Hereditary cancer-predisposing syndrome; Hereditary breast ovari
- N46N (p.Asn46Asn), rs1895600929, gnomAD 15-90749406-T-C, AlphaMissense 0.12, MetaLR 0.09
- V47I (p.Val47Ile), TOPMed rs1895601046, gnomAD rs1895601046, REVEL 0.10, CADD 6.27, Uncertain significance, Hereditary cancer-predisposing syndrome
- S48F (p.Ser48Phe), NCI-TCGA Cosmic COSV6192, cosmic curated COSV61927, REVEL 0.17, CADD 23.00, Variant assessed as somatic; moderate impact.
- S48T (p.Ser48Thr), rs1895601138, ClinGen CA393839450, ClinVar RCV001233520, ClinVar RCV003284091, REVEL 0.08, CADD 19.80, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- S48Y (p.Ser48Tyr), gnomAD 15-90749411-C-A, REVEL 0.18, CADD 22.70
- S48S (p.Ser48Ser), gnomAD 15-90749412-T-C, CADD 7.40
- V49A (p.Val49Ala), rs1895601341, ClinGen CA393839464, ClinVar RCV001243845, ClinVar RCV001819945, REVEL 0.03, CADD 9.14, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome; not specified
- V49I (p.Val49Ile), rs558379347, ClinGen CA7738251, ClinVar RCV001071066, ClinVar RCV002393341, REVEL 0.02, CADD 0.05, Conflicting interpretations, Hereditary cancer-predisposing syndrome; Bloom syndrome
- V49L (p.Val49Leu), NCI-TCGA TCGA novel, REVEL 0.01, CADD 0.11, Variant assessed as somatic; moderate impact.
- V49N (p.Val49Asn), gnomAD 15-90749411-CTG-C, CADD 22.60
- T50S (p.Thr50Ser), cosmic curated COSV10075, Ensembl rs2151146737
- T50N (p.Thr50Asn), gnomAD 15-90749417-C-A, REVEL 0.12, CADD 17.80
- T50T (p.Thr50Thr), rs760605610, gnomAD 15-90749418-T-A, CADD 1.75
- V52M (p.Val52Met), rs2151146745, ClinGen CA393839494, ClinVar RCV002023018, ClinVar RCV003478923, REVEL 0.03, CADD 11.40, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome; not provided
- V52A (p.Val52Ala), gnomAD 15-90749423-T-C, REVEL 0.08, CADD 16.10
- S53A (p.Ser53Ala), rs1555418248, ClinGen CA393839506, ClinVar RCV002405788, ClinVar RCV006470095, AlphaMissense 0.07, MetaLR 0.14, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- S53L (p.Ser53Leu), rs2505390394, ClinGen CA393839511, ClinVar RCV002398401, Uncertain significance, Hereditary cancer-predisposing syndrome
- S53P (p.Ser53Pro), rs1555418248, ClinGen CA393839505, ClinVar RCV002405784, AlphaMissense 0.07, MetaLR 0.14, Uncertain significance, Hereditary cancer-predisposing syndrome
- S53T (p.Ser53Thr), rs1555418248, ClinGen CA393839504, ClinVar RCV000525338, ClinVar RCV005520297, AlphaMissense 0.07, MetaLR 0.14, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- S53* (p.Ser53Ter), gnomAD 15-90749426-C-A, CADD 34.00
- S53S (p.Ser53Ser), rs753606820, gnomAD 15-90749427-A-G, CADD 0.48
- V54A (p.Val54Ala), Ensembl rs2151146758
- V54I (p.Val54Ile), rs2151146756, ClinGen CA393839514, cosmic curated COSV61923, ClinVar RCV004516720, AlphaMissense 0.07, MetaLR 0.22, Uncertain significance, Hereditary cancer-predisposing syndrome
- A55E (p.Ala55Glu), rs1895601835, ClinGen CA393839526, ClinVar RCV004516737, ClinVar RCV005065191, REVEL 0.11, AlphaMissense 0.10, Uncertain significance, Bloom syndrome; Hereditary cancer-predisposing syndrome
- A55G (p.Ala55Gly), rs1895601835, ClinGen CA393839527, ClinVar RCV001368500, ClinVar RCV005520512, AlphaMissense 0.10, MetaLR 0.10, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- A55V (p.Ala55Val), rs1895601835, ClinGen CA393839529, ClinVar RCV001072029, Ensembl rs1895601835, AlphaMissense 0.10, MetaLR 0.10, Uncertain significance, Bloom syndrome
- K56R (p.Lys56Arg), TOPMed rs1222785570, gnomAD rs1222785570, REVEL 0.03, CADD 9.28
- K56E (p.Lys56Glu), gnomAD 15-90749434-A-G, REVEL 0.03, CADD 13.40
- T57A (p.Thr57Ala), rs2505390447, ClinGen CA393839548, ClinVar RCV003278207, Uncertain significance, Hereditary cancer-predisposing syndrome
- T57S (p.Thr57Ser), rs2505390447, ClinGen CA393839550, ClinVar RCV002406282, Uncertain significance, Hereditary cancer-predisposing syndrome
- T57H (p.Thr57His), rs2151146763, gnomAD 15-90749432-CA-C, CADD 13.60
- T57T (p.Thr57Thr), rs1895602030, gnomAD 15-90749439-A-T, CADD 2.73
- P58H (p.Pro58His), TOPMed rs1895602282
- P58R (p.Pro58Arg), TOPMed rs1895602282, Uncertain significance, Hereditary cancer-predisposing syndrome
- P58S (p.Pro58Ser), rs1596217837, ClinGen CA393839560, ClinVar RCV001241907, Ensembl rs1596217837, REVEL 0.04, AlphaMissense 0.07, Uncertain significance, Bloom syndrome
- P58T (p.Pro58Thr), rs1596217837, ClinGen CA393839557, ClinVar RCV000792917, ClinVar RCV001012877, AlphaMissense 0.07, MetaLR 0.15, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- P58P (p.Pro58Pro), rs576862402, gnomAD 15-90749442-T-C, CADD 3.96
- V59I (p.Val59Ile), Ensembl rs2151146790, REVEL 0.08, CADD 15.60
- V59T (p.Val59Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V59V (p.Val59Val), gnomAD 15-90749445-A-G, CADD 6.06
- L60I (p.Leu60Ile), rs138542210, ClinGen CA157427, cosmic curated COSV10590, ClinVar RCV000120241, REVEL 0.10, CADD 19.40, Uncertain significance, Hereditary cancer-predisposing syndrome
- L60* (p.Leu60Ter), gnomAD 15-90749447-T-A, CADD 34.00
- R61I (p.Arg61Ile), rs1060500644, ClinGen CA16614943, cosmic curated COSV61927, ClinVar RCV000465204, REVEL 0.01, CADD 15.10, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- R61K (p.Arg61Lys), NCI-TCGA Cosmic COSV6192, cosmic curated COSV61925, Variant assessed as somatic; moderate impact.
- R61T (p.Arg61Thr), rs1060500644, ClinGen CA393839601, ClinVar RCV002045607, ClinVar RCV003303642, REVEL 0.02, CADD 13.00, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- N62K (p.Asn62Lys), rs146735953, ClinGen CA393839629, ClinVar RCV001367349, ESP rs146735953, REVEL 0.03, CADD 15.50, Uncertain significance, Bloom syndrome
- D64A (p.Asp64Ala), rs140382474, ClinGen CA10605706, ClinVar RCV000360928, ClinVar RCV000552084, REVEL 0.20, AlphaMissense 0.16, Uncertain significance, Hereditary cancer-predisposing syndrome; not provided; Bloom syndrome
- D64G (p.Asp64Gly), rs140382474, ClinGen CA393839658, ClinVar RCV000503861, ESP rs140382474, AlphaMissense 0.16, MetaLR 0.17, Uncertain significance, not specified
- D64H (p.Asp64His), rs1895602796, ClinGen CA393839653, cosmic curated COSV61921, ClinVar RCV001205505, AlphaMissense 0.27, MetaLR 0.30, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- D64V (p.Asp64Val), rs140382474, ClinGen CA243084, cosmic curated COSV10466, ClinVar RCV000460513, REVEL 0.31, AlphaMissense 0.16, Conflicting interpretations, Hereditary cancer-predisposing syndrome; not specified; not provided
- D64Y (p.Asp64Tyr), rs1895602796, ClinGen CA393839654, ClinVar RCV002410521, ClinVar RCV005097830, REVEL 0.27, AlphaMissense 0.27, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- V65D (p.Val65Asp), rs2505390617, ClinGen CA393839668, ClinVar RCV004518867, Uncertain significance, Hereditary cancer-predisposing syndrome
- V65I (p.Val65Ile), rs1895603124, ClinGen CA393839665, ClinVar RCV001223053, Ensembl rs1895603124, REVEL 0.16, CADD 21.30, Uncertain significance, Bloom syndrome
- V65L (p.Val65Leu), rs1895603124, ClinGen CA393839666, ClinVar RCV003172624, Ensembl rs1895603124, REVEL 0.14, CADD 21.60, Uncertain significance, Hereditary cancer-predisposing syndrome
- N66D (p.Asn66Asp), rs2505390627, ClinGen CA393839673, ClinVar RCV003005699, Uncertain significance, Bloom syndrome
- N66Y (p.Asn66Tyr), gnomAD 15-90749464-A-T, REVEL 0.25, CADD 23.80
- N66I (p.Asn66Ile), gnomAD 15-90749465-A-T, REVEL 0.15, CADD 19.00
- N66N (p.Asn66Asn), rs1410899563, gnomAD 15-90749466-T-C, CADD 5.65
- V67D (p.Val67Asp), rs1555418261, ClinGen CA393839701, ClinVar RCV000564482, Ensembl rs1555418261, AlphaMissense 0.16, MetaLR 0.16, Uncertain significance, Hereditary cancer-predisposing syndrome
- V67I (p.Val67Ile), rs991350762, ClinGen CA274727689, cosmic curated COSV10526, ClinVar RCV000709354, REVEL 0.05, CADD 7.93, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- V67V (p.Val67Val), rs563887813, gnomAD 15-90749469-T-C, CADD 1.27
- T68I (p.Thr68Ile), cosmic curated COSV10743, ESP rs144134597, ExAC rs144134597, TOPMed rs144134597, Uncertain significance
- T68N (p.Thr68Asn), rs144134597, ClinGen CA7738257, ClinVar RCV002023486, ClinVar RCV002423269, REVEL 0.11, CADD 6.77, Uncertain significance, Bloom syndrome; Hereditary cancer-predisposing syndrome
- T68T (p.Thr68Thr), rs199927688, gnomAD 15-90749472-C-G, CADD 0.04
- E69* (p.Glu69Ter), rs746195311, ClinGen CA393839723, ClinVar RCV000579258, ExAC rs746195311, AlphaMissense 0.07, MetaLR 0.09, Pathogenic
- E69K (p.Glu69Lys), rs746195311, ClinGen CA235943, cosmic curated COSV61925, ClinVar RCV000171242, REVEL 0.04, AlphaMissense 0.07, Conflicting interpretations, Hereditary cancer-predisposing syndrome; not specified; not provided
- E69Q (p.Glu69Gln), ExAC rs746195311, TOPMed rs746195311, gnomAD rs746195311, Pathogenic
- D70E (p.Asp70Glu), Ensembl rs2151146852, Uncertain significance, Hereditary cancer-predisposing syndrome
- D70G (p.Asp70Gly), rs2151146849, ClinGen CA393839749, cosmic curated COSV10526, ClinVar RCV002033301, REVEL 0.02, CADD 1.04, Uncertain significance, Bloom syndrome
- D70N (p.Asp70Asn), rs769957028, ClinGen CA7738260, ClinVar RCV000628617, ClinVar RCV001014393, REVEL 0.07, CADD 13.30, Uncertain significance, not provided; Hereditary cancer-predisposing syndrome; Bloom syndrome
- D70Y (p.Asp70Tyr), ExAC rs769957028, gnomAD rs769957028, REVEL 0.02, CADD 9.12, Uncertain significance
- F71C (p.Phe71Cys), rs2505390783, ClinGen CA393839769, ClinVar RCV002417758, Uncertain significance, Hereditary cancer-predisposing syndrome
- F71I (p.Phe71Ile), rs2151146855, ClinGen CA393839762, ClinVar RCV002814616, ClinVar RCV004064867, AlphaMissense 0.33, MetaLR 0.07, Uncertain significance, Hereditary cancer-predisposing syndrome; Bloom syndrome
- F71L (p.Phe71Leu), rs2151146855, ClinGen CA393839763, ClinVar RCV001988600, Ensembl rs2151146855, AlphaMissense 0.33, MetaLR 0.07, Uncertain significance, Bloom syndrome
- F71V (p.Phe71Val), Ensembl rs2151146855, Uncertain significance
Public BLM analysis runs
- BLM analysis run — BLM (3,337 variants) — completed 2026-08-21